Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.711 USD | -1.92% | -3.92% | -77.79% |
05-22 | Maxim Downgrades Virpax Pharmaceuticals to Hold From Buy | MT |
05-15 | Virpax Prices Public Offering of Shares, Warrants; Shares Tumble | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-77.79% | 849K | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- VRPX Stock
- News Virpax Pharmaceuticals, Inc.
- Virpax Pharmaceuticals Says it has Received Pre-IND Application Guidance From the US FDA on NobrXiol's Development